The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.
Related Posts
Trump’s approach to Ukraine could be ‘very worrying’ for Russia’s neighbors, former UK PM Cameron says
Former U.K. Prime Minister David Cameron on Thursday said he is fearful that U.S. President Donald Trump’s approach to Ukraine could set an alarming precedent.
Domino’s Pizza wants to steal market share as it wins over low-income diners
Domino’s Pizza saw its U.S. same-store sales rise 3.4% in its latest quarter.
Germany’s auto giants were already reeling. Now Trump wants to turn them into American companies
For Germany, the prospect of U.S. tariffs on European autos comes at a time when it’s top original equipment manufacturers (OEMs) are already reeling.